nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—SLCO1B1—Penicillamine—rheumatoid arthritis	0.174	0.271	CbGbCtD
Sirolimus—FKBP1A—Cyclosporine—rheumatoid arthritis	0.155	0.242	CbGbCtD
Sirolimus—SLCO1B1—Sulfasalazine—rheumatoid arthritis	0.0338	0.0528	CbGbCtD
Sirolimus—SLCO1B1—Cyclosporine—rheumatoid arthritis	0.0256	0.04	CbGbCtD
Sirolimus—CYP3A7—Hydrocortisone—rheumatoid arthritis	0.0159	0.0248	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Hydrocortisone—rheumatoid arthritis	0.0159	0.0248	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Cyclosporine—rheumatoid arthritis	0.015	0.0235	CbGbCtD
Sirolimus—CYP3A7—Cyclosporine—rheumatoid arthritis	0.015	0.0235	CbGbCtD
Sirolimus—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0149	0.0232	CbGbCtD
Sirolimus—SLCO1B1—Methotrexate—rheumatoid arthritis	0.0136	0.0212	CbGbCtD
Sirolimus—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0128	0.0199	CbGbCtD
Sirolimus—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0119	0.0186	CbGbCtD
Sirolimus—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0113	0.0176	CbGbCtD
Sirolimus—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0104	0.0162	CbGbCtD
Sirolimus—CYP3A7—Dexamethasone—rheumatoid arthritis	0.00991	0.0155	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Dexamethasone—rheumatoid arthritis	0.00991	0.0155	CbGbCtD
Sirolimus—ABCB1—Betamethasone—rheumatoid arthritis	0.00831	0.013	CbGbCtD
Sirolimus—ABCB1—Prednisolone—rheumatoid arthritis	0.0082	0.0128	CbGbCtD
Sirolimus—ABCB1—Hydrocortisone—rheumatoid arthritis	0.00778	0.0121	CbGbCtD
Sirolimus—ABCB1—Prednisone—rheumatoid arthritis	0.00775	0.0121	CbGbCtD
Sirolimus—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00766	0.012	CbGbCtD
Sirolimus—CYP3A5—Dexamethasone—rheumatoid arthritis	0.00743	0.0116	CbGbCtD
Sirolimus—ABCB1—Cyclosporine—rheumatoid arthritis	0.00734	0.0115	CbGbCtD
Sirolimus—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00581	0.00906	CbGbCtD
Sirolimus—CYP3A4—Betamethasone—rheumatoid arthritis	0.00498	0.00777	CbGbCtD
Sirolimus—CYP3A4—Prednisolone—rheumatoid arthritis	0.00492	0.00767	CbGbCtD
Sirolimus—ABCB1—Dexamethasone—rheumatoid arthritis	0.00484	0.00754	CbGbCtD
Sirolimus—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00466	0.00727	CbGbCtD
Sirolimus—CYP3A4—Prednisone—rheumatoid arthritis	0.00464	0.00724	CbGbCtD
Sirolimus—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0044	0.00686	CbGbCtD
Sirolimus—ABCB1—Methotrexate—rheumatoid arthritis	0.00389	0.00606	CbGbCtD
Sirolimus—CYP3A4—Dexamethasone—rheumatoid arthritis	0.0029	0.00452	CbGbCtD
Sirolimus—EIF4E—connective tissue—rheumatoid arthritis	0.000973	0.163	CbGeAlD
Sirolimus—EIF4E—lymphoid tissue—rheumatoid arthritis	0.000711	0.119	CbGeAlD
Sirolimus—EIF4E—digestive system—rheumatoid arthritis	0.000703	0.118	CbGeAlD
Sirolimus—FGF2—tendon—rheumatoid arthritis	0.000408	0.0684	CbGeAlD
Sirolimus—MTOR—connective tissue—rheumatoid arthritis	0.000376	0.0632	CbGeAlD
Sirolimus—FKBP1A—connective tissue—rheumatoid arthritis	0.000339	0.0568	CbGeAlD
Sirolimus—MTOR—lymphoid tissue—rheumatoid arthritis	0.000275	0.0462	CbGeAlD
Sirolimus—MTOR—digestive system—rheumatoid arthritis	0.000272	0.0456	CbGeAlD
Sirolimus—MTOR—tendon—rheumatoid arthritis	0.000259	0.0434	CbGeAlD
Sirolimus—FKBP1A—lymphoid tissue—rheumatoid arthritis	0.000248	0.0415	CbGeAlD
Sirolimus—FKBP1A—digestive system—rheumatoid arthritis	0.000245	0.041	CbGeAlD
Sirolimus—FKBP1A—tendon—rheumatoid arthritis	0.000233	0.0391	CbGeAlD
Sirolimus—SLC47A1—digestive system—rheumatoid arthritis	0.00021	0.0353	CbGeAlD
Sirolimus—SLCO1B1—digestive system—rheumatoid arthritis	0.000207	0.0348	CbGeAlD
Sirolimus—SLC47A1—tendon—rheumatoid arthritis	0.0002	0.0336	CbGeAlD
Sirolimus—CYP3A5—digestive system—rheumatoid arthritis	0.000106	0.0179	CbGeAlD
Sirolimus—CYP3A4—digestive system—rheumatoid arthritis	7.99e-05	0.0134	CbGeAlD
Sirolimus—ABCB1—lymphoid tissue—rheumatoid arthritis	5.73e-05	0.00961	CbGeAlD
Sirolimus—ABCB1—digestive system—rheumatoid arthritis	5.66e-05	0.00949	CbGeAlD
Sirolimus—Nausea—Azathioprine—rheumatoid arthritis	5.65e-05	0.000264	CcSEcCtD
Sirolimus—Tachycardia—Methylprednisolone—rheumatoid arthritis	5.65e-05	0.000264	CcSEcCtD
Sirolimus—Headache—Leflunomide—rheumatoid arthritis	5.63e-05	0.000263	CcSEcCtD
Sirolimus—Skin disorder—Methylprednisolone—rheumatoid arthritis	5.63e-05	0.000262	CcSEcCtD
Sirolimus—Malnutrition—Prednisone—rheumatoid arthritis	5.62e-05	0.000262	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	5.62e-05	0.000262	CcSEcCtD
Sirolimus—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	5.61e-05	0.000262	CcSEcCtD
Sirolimus—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	5.6e-05	0.000261	CcSEcCtD
Sirolimus—Insomnia—Hydrocortisone—rheumatoid arthritis	5.58e-05	0.00026	CcSEcCtD
Sirolimus—Hypertension—Dexamethasone—rheumatoid arthritis	5.57e-05	0.00026	CcSEcCtD
Sirolimus—Hypertension—Betamethasone—rheumatoid arthritis	5.57e-05	0.00026	CcSEcCtD
Sirolimus—Paraesthesia—Hydrocortisone—rheumatoid arthritis	5.54e-05	0.000258	CcSEcCtD
Sirolimus—Myalgia—Dexamethasone—rheumatoid arthritis	5.49e-05	0.000256	CcSEcCtD
Sirolimus—Myalgia—Betamethasone—rheumatoid arthritis	5.49e-05	0.000256	CcSEcCtD
Sirolimus—Abdominal pain—Cyclosporine—rheumatoid arthritis	5.48e-05	0.000256	CcSEcCtD
Sirolimus—Body temperature increased—Cyclosporine—rheumatoid arthritis	5.48e-05	0.000256	CcSEcCtD
Sirolimus—Anxiety—Betamethasone—rheumatoid arthritis	5.48e-05	0.000255	CcSEcCtD
Sirolimus—Anxiety—Dexamethasone—rheumatoid arthritis	5.48e-05	0.000255	CcSEcCtD
Sirolimus—Discomfort—Betamethasone—rheumatoid arthritis	5.43e-05	0.000253	CcSEcCtD
Sirolimus—Discomfort—Dexamethasone—rheumatoid arthritis	5.43e-05	0.000253	CcSEcCtD
Sirolimus—Dyspepsia—Hydrocortisone—rheumatoid arthritis	5.43e-05	0.000253	CcSEcCtD
Sirolimus—Haemoglobin—Methotrexate—rheumatoid arthritis	5.42e-05	0.000253	CcSEcCtD
Sirolimus—Hypotension—Methylprednisolone—rheumatoid arthritis	5.41e-05	0.000252	CcSEcCtD
Sirolimus—Pain—Prednisolone—rheumatoid arthritis	5.4e-05	0.000252	CcSEcCtD
Sirolimus—Haemorrhage—Methotrexate—rheumatoid arthritis	5.4e-05	0.000252	CcSEcCtD
Sirolimus—Decreased appetite—Hydrocortisone—rheumatoid arthritis	5.36e-05	0.00025	CcSEcCtD
Sirolimus—Pharyngitis—Methotrexate—rheumatoid arthritis	5.36e-05	0.00025	CcSEcCtD
Sirolimus—Nausea—Leflunomide—rheumatoid arthritis	5.34e-05	0.000249	CcSEcCtD
Sirolimus—Urinary tract disorder—Methotrexate—rheumatoid arthritis	5.33e-05	0.000249	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	5.32e-05	0.000248	CcSEcCtD
Sirolimus—Urethral disorder—Methotrexate—rheumatoid arthritis	5.29e-05	0.000247	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	5.29e-05	0.000247	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	5.28e-05	0.000246	CcSEcCtD
Sirolimus—Pain—Hydrocortisone—rheumatoid arthritis	5.27e-05	0.000246	CcSEcCtD
Sirolimus—Anaphylactic shock—Betamethasone—rheumatoid arthritis	5.27e-05	0.000246	CcSEcCtD
Sirolimus—Oedema—Betamethasone—rheumatoid arthritis	5.27e-05	0.000246	CcSEcCtD
Sirolimus—Oedema—Dexamethasone—rheumatoid arthritis	5.27e-05	0.000246	CcSEcCtD
Sirolimus—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	5.27e-05	0.000246	CcSEcCtD
Sirolimus—Insomnia—Triamcinolone—rheumatoid arthritis	5.25e-05	0.000245	CcSEcCtD
Sirolimus—Insomnia—Methylprednisolone—rheumatoid arthritis	5.24e-05	0.000244	CcSEcCtD
Sirolimus—Infection—Dexamethasone—rheumatoid arthritis	5.23e-05	0.000244	CcSEcCtD
Sirolimus—Infection—Betamethasone—rheumatoid arthritis	5.23e-05	0.000244	CcSEcCtD
Sirolimus—Ill-defined disorder—Prednisone—rheumatoid arthritis	5.21e-05	0.000243	CcSEcCtD
Sirolimus—Paraesthesia—Triamcinolone—rheumatoid arthritis	5.21e-05	0.000243	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisolone—rheumatoid arthritis	5.2e-05	0.000243	CcSEcCtD
Sirolimus—Paraesthesia—Methylprednisolone—rheumatoid arthritis	5.2e-05	0.000243	CcSEcCtD
Sirolimus—Visual impairment—Methotrexate—rheumatoid arthritis	5.2e-05	0.000243	CcSEcCtD
Sirolimus—Anaemia—Prednisone—rheumatoid arthritis	5.19e-05	0.000242	CcSEcCtD
Sirolimus—Shock—Dexamethasone—rheumatoid arthritis	5.18e-05	0.000242	CcSEcCtD
Sirolimus—Shock—Betamethasone—rheumatoid arthritis	5.18e-05	0.000242	CcSEcCtD
Sirolimus—Dyspnoea—Triamcinolone—rheumatoid arthritis	5.18e-05	0.000241	CcSEcCtD
Sirolimus—Nervous system disorder—Betamethasone—rheumatoid arthritis	5.17e-05	0.000241	CcSEcCtD
Sirolimus—Nervous system disorder—Dexamethasone—rheumatoid arthritis	5.17e-05	0.000241	CcSEcCtD
Sirolimus—Agitation—Prednisone—rheumatoid arthritis	5.17e-05	0.000241	CcSEcCtD
Sirolimus—Thrombocytopenia—Betamethasone—rheumatoid arthritis	5.16e-05	0.000241	CcSEcCtD
Sirolimus—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	5.16e-05	0.000241	CcSEcCtD
Sirolimus—Tachycardia—Dexamethasone—rheumatoid arthritis	5.14e-05	0.00024	CcSEcCtD
Sirolimus—Tachycardia—Betamethasone—rheumatoid arthritis	5.14e-05	0.00024	CcSEcCtD
Sirolimus—Angioedema—Prednisone—rheumatoid arthritis	5.14e-05	0.00024	CcSEcCtD
Sirolimus—Hypersensitivity—Cyclosporine—rheumatoid arthritis	5.11e-05	0.000238	CcSEcCtD
Sirolimus—Dyspepsia—Triamcinolone—rheumatoid arthritis	5.11e-05	0.000238	CcSEcCtD
Sirolimus—Dyspepsia—Methylprednisolone—rheumatoid arthritis	5.1e-05	0.000238	CcSEcCtD
Sirolimus—Hyperhidrosis—Betamethasone—rheumatoid arthritis	5.09e-05	0.000238	CcSEcCtD
Sirolimus—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	5.09e-05	0.000238	CcSEcCtD
Sirolimus—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	5.08e-05	0.000237	CcSEcCtD
Sirolimus—Malaise—Prednisone—rheumatoid arthritis	5.07e-05	0.000236	CcSEcCtD
Sirolimus—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	5.04e-05	0.000235	CcSEcCtD
Sirolimus—Syncope—Prednisone—rheumatoid arthritis	5.04e-05	0.000235	CcSEcCtD
Sirolimus—Tinnitus—Methotrexate—rheumatoid arthritis	5.03e-05	0.000235	CcSEcCtD
Sirolimus—Anorexia—Dexamethasone—rheumatoid arthritis	5.02e-05	0.000234	CcSEcCtD
Sirolimus—Anorexia—Betamethasone—rheumatoid arthritis	5.02e-05	0.000234	CcSEcCtD
Sirolimus—Cardiac disorder—Methotrexate—rheumatoid arthritis	5.01e-05	0.000234	CcSEcCtD
Sirolimus—Asthenia—Cyclosporine—rheumatoid arthritis	4.98e-05	0.000232	CcSEcCtD
Sirolimus—Pain—Triamcinolone—rheumatoid arthritis	4.96e-05	0.000232	CcSEcCtD
Sirolimus—Loss of consciousness—Prednisone—rheumatoid arthritis	4.94e-05	0.00023	CcSEcCtD
Sirolimus—Hypotension—Dexamethasone—rheumatoid arthritis	4.92e-05	0.00023	CcSEcCtD
Sirolimus—Hypotension—Betamethasone—rheumatoid arthritis	4.92e-05	0.00023	CcSEcCtD
Sirolimus—Pruritus—Cyclosporine—rheumatoid arthritis	4.91e-05	0.000229	CcSEcCtD
Sirolimus—Angiopathy—Methotrexate—rheumatoid arthritis	4.9e-05	0.000228	CcSEcCtD
Sirolimus—Immune system disorder—Methotrexate—rheumatoid arthritis	4.87e-05	0.000227	CcSEcCtD
Sirolimus—Body temperature increased—Hydrocortisone—rheumatoid arthritis	4.87e-05	0.000227	CcSEcCtD
Sirolimus—Abdominal pain—Hydrocortisone—rheumatoid arthritis	4.87e-05	0.000227	CcSEcCtD
Sirolimus—Mediastinal disorder—Methotrexate—rheumatoid arthritis	4.86e-05	0.000227	CcSEcCtD
Sirolimus—Hypertension—Prednisone—rheumatoid arthritis	4.85e-05	0.000226	CcSEcCtD
Sirolimus—Chills—Methotrexate—rheumatoid arthritis	4.84e-05	0.000226	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	4.8e-05	0.000224	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	4.8e-05	0.000224	CcSEcCtD
Sirolimus—Myalgia—Prednisone—rheumatoid arthritis	4.79e-05	0.000223	CcSEcCtD
Sirolimus—Arthralgia—Prednisone—rheumatoid arthritis	4.79e-05	0.000223	CcSEcCtD
Sirolimus—Feeling abnormal—Triamcinolone—rheumatoid arthritis	4.78e-05	0.000223	CcSEcCtD
Sirolimus—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	4.77e-05	0.000223	CcSEcCtD
Sirolimus—Anxiety—Prednisone—rheumatoid arthritis	4.77e-05	0.000222	CcSEcCtD
Sirolimus—Insomnia—Dexamethasone—rheumatoid arthritis	4.76e-05	0.000222	CcSEcCtD
Sirolimus—Insomnia—Betamethasone—rheumatoid arthritis	4.76e-05	0.000222	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	4.75e-05	0.000222	CcSEcCtD
Sirolimus—Diarrhoea—Cyclosporine—rheumatoid arthritis	4.75e-05	0.000221	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	4.74e-05	0.000221	CcSEcCtD
Sirolimus—Paraesthesia—Betamethasone—rheumatoid arthritis	4.73e-05	0.000221	CcSEcCtD
Sirolimus—Paraesthesia—Dexamethasone—rheumatoid arthritis	4.73e-05	0.000221	CcSEcCtD
Sirolimus—Discomfort—Prednisone—rheumatoid arthritis	4.73e-05	0.000221	CcSEcCtD
Sirolimus—Malnutrition—Methotrexate—rheumatoid arthritis	4.7e-05	0.000219	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisolone—rheumatoid arthritis	4.65e-05	0.000217	CcSEcCtD
Sirolimus—Dyspepsia—Dexamethasone—rheumatoid arthritis	4.64e-05	0.000216	CcSEcCtD
Sirolimus—Dyspepsia—Betamethasone—rheumatoid arthritis	4.64e-05	0.000216	CcSEcCtD
Sirolimus—Body temperature increased—Triamcinolone—rheumatoid arthritis	4.59e-05	0.000214	CcSEcCtD
Sirolimus—Dizziness—Cyclosporine—rheumatoid arthritis	4.59e-05	0.000214	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisone—rheumatoid arthritis	4.59e-05	0.000214	CcSEcCtD
Sirolimus—Oedema—Prednisone—rheumatoid arthritis	4.59e-05	0.000214	CcSEcCtD
Sirolimus—Abdominal pain—Methylprednisolone—rheumatoid arthritis	4.58e-05	0.000214	CcSEcCtD
Sirolimus—Decreased appetite—Dexamethasone—rheumatoid arthritis	4.58e-05	0.000214	CcSEcCtD
Sirolimus—Decreased appetite—Betamethasone—rheumatoid arthritis	4.58e-05	0.000214	CcSEcCtD
Sirolimus—Infection—Prednisone—rheumatoid arthritis	4.56e-05	0.000213	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	4.55e-05	0.000212	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	4.55e-05	0.000212	CcSEcCtD
Sirolimus—Back pain—Methotrexate—rheumatoid arthritis	4.54e-05	0.000212	CcSEcCtD
Sirolimus—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	4.54e-05	0.000212	CcSEcCtD
Sirolimus—Shock—Prednisone—rheumatoid arthritis	4.51e-05	0.000211	CcSEcCtD
Sirolimus—Pain—Betamethasone—rheumatoid arthritis	4.5e-05	0.00021	CcSEcCtD
Sirolimus—Pain—Dexamethasone—rheumatoid arthritis	4.5e-05	0.00021	CcSEcCtD
Sirolimus—Nervous system disorder—Prednisone—rheumatoid arthritis	4.5e-05	0.00021	CcSEcCtD
Sirolimus—Tachycardia—Prednisone—rheumatoid arthritis	4.48e-05	0.000209	CcSEcCtD
Sirolimus—Skin disorder—Prednisone—rheumatoid arthritis	4.46e-05	0.000208	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisone—rheumatoid arthritis	4.43e-05	0.000207	CcSEcCtD
Sirolimus—Asthenia—Hydrocortisone—rheumatoid arthritis	4.42e-05	0.000206	CcSEcCtD
Sirolimus—Vomiting—Cyclosporine—rheumatoid arthritis	4.41e-05	0.000206	CcSEcCtD
Sirolimus—Rash—Cyclosporine—rheumatoid arthritis	4.37e-05	0.000204	CcSEcCtD
Sirolimus—Anorexia—Prednisone—rheumatoid arthritis	4.37e-05	0.000204	CcSEcCtD
Sirolimus—Dermatitis—Cyclosporine—rheumatoid arthritis	4.37e-05	0.000204	CcSEcCtD
Sirolimus—Pruritus—Hydrocortisone—rheumatoid arthritis	4.36e-05	0.000203	CcSEcCtD
Sirolimus—Ill-defined disorder—Methotrexate—rheumatoid arthritis	4.36e-05	0.000203	CcSEcCtD
Sirolimus—Headache—Cyclosporine—rheumatoid arthritis	4.35e-05	0.000203	CcSEcCtD
Sirolimus—Anaemia—Methotrexate—rheumatoid arthritis	4.34e-05	0.000203	CcSEcCtD
Sirolimus—Feeling abnormal—Dexamethasone—rheumatoid arthritis	4.34e-05	0.000202	CcSEcCtD
Sirolimus—Feeling abnormal—Betamethasone—rheumatoid arthritis	4.34e-05	0.000202	CcSEcCtD
Sirolimus—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	4.31e-05	0.000201	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	4.31e-05	0.000201	CcSEcCtD
Sirolimus—Hypersensitivity—Triamcinolone—rheumatoid arthritis	4.28e-05	0.0002	CcSEcCtD
Sirolimus—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	4.27e-05	0.000199	CcSEcCtD
Sirolimus—Malaise—Methotrexate—rheumatoid arthritis	4.24e-05	0.000198	CcSEcCtD
Sirolimus—Diarrhoea—Hydrocortisone—rheumatoid arthritis	4.22e-05	0.000197	CcSEcCtD
Sirolimus—Leukopenia—Methotrexate—rheumatoid arthritis	4.2e-05	0.000196	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	4.18e-05	0.000195	CcSEcCtD
Sirolimus—Dizziness—Prednisolone—rheumatoid arthritis	4.17e-05	0.000195	CcSEcCtD
Sirolimus—Asthenia—Triamcinolone—rheumatoid arthritis	4.16e-05	0.000194	CcSEcCtD
Sirolimus—Abdominal pain—Betamethasone—rheumatoid arthritis	4.16e-05	0.000194	CcSEcCtD
Sirolimus—Body temperature increased—Dexamethasone—rheumatoid arthritis	4.16e-05	0.000194	CcSEcCtD
Sirolimus—Abdominal pain—Dexamethasone—rheumatoid arthritis	4.16e-05	0.000194	CcSEcCtD
Sirolimus—Body temperature increased—Betamethasone—rheumatoid arthritis	4.16e-05	0.000194	CcSEcCtD
Sirolimus—Asthenia—Methylprednisolone—rheumatoid arthritis	4.16e-05	0.000194	CcSEcCtD
Sirolimus—Insomnia—Prednisone—rheumatoid arthritis	4.15e-05	0.000194	CcSEcCtD
Sirolimus—Nausea—Cyclosporine—rheumatoid arthritis	4.12e-05	0.000192	CcSEcCtD
Sirolimus—Paraesthesia—Prednisone—rheumatoid arthritis	4.12e-05	0.000192	CcSEcCtD
Sirolimus—Pruritus—Triamcinolone—rheumatoid arthritis	4.11e-05	0.000192	CcSEcCtD
Sirolimus—Cough—Methotrexate—rheumatoid arthritis	4.1e-05	0.000191	CcSEcCtD
Sirolimus—Pruritus—Methylprednisolone—rheumatoid arthritis	4.1e-05	0.000191	CcSEcCtD
Sirolimus—Dizziness—Hydrocortisone—rheumatoid arthritis	4.08e-05	0.00019	CcSEcCtD
Sirolimus—Dyspepsia—Prednisone—rheumatoid arthritis	4.04e-05	0.000188	CcSEcCtD
Sirolimus—Chest pain—Methotrexate—rheumatoid arthritis	4e-05	0.000187	CcSEcCtD
Sirolimus—Arthralgia—Methotrexate—rheumatoid arthritis	4e-05	0.000187	CcSEcCtD
Sirolimus—Myalgia—Methotrexate—rheumatoid arthritis	4e-05	0.000187	CcSEcCtD
Sirolimus—Decreased appetite—Prednisone—rheumatoid arthritis	3.99e-05	0.000186	CcSEcCtD
Sirolimus—Rash—Prednisolone—rheumatoid arthritis	3.98e-05	0.000186	CcSEcCtD
Sirolimus—Dermatitis—Prednisolone—rheumatoid arthritis	3.98e-05	0.000186	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	3.97e-05	0.000185	CcSEcCtD
Sirolimus—Diarrhoea—Methylprednisolone—rheumatoid arthritis	3.96e-05	0.000185	CcSEcCtD
Sirolimus—Headache—Prednisolone—rheumatoid arthritis	3.95e-05	0.000184	CcSEcCtD
Sirolimus—Discomfort—Methotrexate—rheumatoid arthritis	3.95e-05	0.000184	CcSEcCtD
Sirolimus—Constipation—Prednisone—rheumatoid arthritis	3.92e-05	0.000183	CcSEcCtD
Sirolimus—Vomiting—Hydrocortisone—rheumatoid arthritis	3.92e-05	0.000183	CcSEcCtD
Sirolimus—Rash—Hydrocortisone—rheumatoid arthritis	3.89e-05	0.000181	CcSEcCtD
Sirolimus—Dermatitis—Hydrocortisone—rheumatoid arthritis	3.88e-05	0.000181	CcSEcCtD
Sirolimus—Confusional state—Methotrexate—rheumatoid arthritis	3.87e-05	0.00018	CcSEcCtD
Sirolimus—Headache—Hydrocortisone—rheumatoid arthritis	3.86e-05	0.00018	CcSEcCtD
Sirolimus—Dizziness—Triamcinolone—rheumatoid arthritis	3.84e-05	0.000179	CcSEcCtD
Sirolimus—Anaphylactic shock—Methotrexate—rheumatoid arthritis	3.83e-05	0.000179	CcSEcCtD
Sirolimus—Dizziness—Methylprednisolone—rheumatoid arthritis	3.83e-05	0.000179	CcSEcCtD
Sirolimus—Infection—Methotrexate—rheumatoid arthritis	3.81e-05	0.000178	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisone—rheumatoid arthritis	3.78e-05	0.000176	CcSEcCtD
Sirolimus—Asthenia—Dexamethasone—rheumatoid arthritis	3.78e-05	0.000176	CcSEcCtD
Sirolimus—Asthenia—Betamethasone—rheumatoid arthritis	3.78e-05	0.000176	CcSEcCtD
Sirolimus—Nervous system disorder—Methotrexate—rheumatoid arthritis	3.76e-05	0.000175	CcSEcCtD
Sirolimus—Thrombocytopenia—Methotrexate—rheumatoid arthritis	3.75e-05	0.000175	CcSEcCtD
Sirolimus—Gastrointestinal pain—Prednisone—rheumatoid arthritis	3.75e-05	0.000175	CcSEcCtD
Sirolimus—Nausea—Prednisolone—rheumatoid arthritis	3.75e-05	0.000175	CcSEcCtD
Sirolimus—Pruritus—Dexamethasone—rheumatoid arthritis	3.73e-05	0.000174	CcSEcCtD
Sirolimus—Pruritus—Betamethasone—rheumatoid arthritis	3.73e-05	0.000174	CcSEcCtD
Sirolimus—Skin disorder—Methotrexate—rheumatoid arthritis	3.72e-05	0.000174	CcSEcCtD
Sirolimus—Hyperhidrosis—Methotrexate—rheumatoid arthritis	3.71e-05	0.000173	CcSEcCtD
Sirolimus—Vomiting—Triamcinolone—rheumatoid arthritis	3.69e-05	0.000172	CcSEcCtD
Sirolimus—Vomiting—Methylprednisolone—rheumatoid arthritis	3.68e-05	0.000172	CcSEcCtD
Sirolimus—Nausea—Hydrocortisone—rheumatoid arthritis	3.66e-05	0.000171	CcSEcCtD
Sirolimus—Rash—Triamcinolone—rheumatoid arthritis	3.66e-05	0.000171	CcSEcCtD
Sirolimus—Dermatitis—Triamcinolone—rheumatoid arthritis	3.66e-05	0.000171	CcSEcCtD
Sirolimus—Anorexia—Methotrexate—rheumatoid arthritis	3.65e-05	0.00017	CcSEcCtD
Sirolimus—Rash—Methylprednisolone—rheumatoid arthritis	3.65e-05	0.00017	CcSEcCtD
Sirolimus—Dermatitis—Methylprednisolone—rheumatoid arthritis	3.65e-05	0.00017	CcSEcCtD
Sirolimus—Headache—Triamcinolone—rheumatoid arthritis	3.64e-05	0.00017	CcSEcCtD
Sirolimus—Headache—Methylprednisolone—rheumatoid arthritis	3.63e-05	0.000169	CcSEcCtD
Sirolimus—Abdominal pain—Prednisone—rheumatoid arthritis	3.63e-05	0.000169	CcSEcCtD
Sirolimus—Body temperature increased—Prednisone—rheumatoid arthritis	3.63e-05	0.000169	CcSEcCtD
Sirolimus—Diarrhoea—Betamethasone—rheumatoid arthritis	3.6e-05	0.000168	CcSEcCtD
Sirolimus—Diarrhoea—Dexamethasone—rheumatoid arthritis	3.6e-05	0.000168	CcSEcCtD
Sirolimus—Hypotension—Methotrexate—rheumatoid arthritis	3.58e-05	0.000167	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	3.49e-05	0.000163	CcSEcCtD
Sirolimus—Dizziness—Betamethasone—rheumatoid arthritis	3.48e-05	0.000162	CcSEcCtD
Sirolimus—Dizziness—Dexamethasone—rheumatoid arthritis	3.48e-05	0.000162	CcSEcCtD
Sirolimus—Insomnia—Methotrexate—rheumatoid arthritis	3.47e-05	0.000162	CcSEcCtD
Sirolimus—Nausea—Triamcinolone—rheumatoid arthritis	3.45e-05	0.000161	CcSEcCtD
Sirolimus—Paraesthesia—Methotrexate—rheumatoid arthritis	3.44e-05	0.000161	CcSEcCtD
Sirolimus—Nausea—Methylprednisolone—rheumatoid arthritis	3.44e-05	0.000161	CcSEcCtD
Sirolimus—Dyspnoea—Methotrexate—rheumatoid arthritis	3.42e-05	0.000159	CcSEcCtD
Sirolimus—Somnolence—Methotrexate—rheumatoid arthritis	3.41e-05	0.000159	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisone—rheumatoid arthritis	3.38e-05	0.000158	CcSEcCtD
Sirolimus—Dyspepsia—Methotrexate—rheumatoid arthritis	3.37e-05	0.000157	CcSEcCtD
Sirolimus—Vomiting—Betamethasone—rheumatoid arthritis	3.35e-05	0.000156	CcSEcCtD
Sirolimus—Vomiting—Dexamethasone—rheumatoid arthritis	3.35e-05	0.000156	CcSEcCtD
Sirolimus—Decreased appetite—Methotrexate—rheumatoid arthritis	3.33e-05	0.000155	CcSEcCtD
Sirolimus—Rash—Dexamethasone—rheumatoid arthritis	3.32e-05	0.000155	CcSEcCtD
Sirolimus—Rash—Betamethasone—rheumatoid arthritis	3.32e-05	0.000155	CcSEcCtD
Sirolimus—Dermatitis—Dexamethasone—rheumatoid arthritis	3.32e-05	0.000155	CcSEcCtD
Sirolimus—Dermatitis—Betamethasone—rheumatoid arthritis	3.32e-05	0.000155	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	3.31e-05	0.000154	CcSEcCtD
Sirolimus—Headache—Dexamethasone—rheumatoid arthritis	3.3e-05	0.000154	CcSEcCtD
Sirolimus—Headache—Betamethasone—rheumatoid arthritis	3.3e-05	0.000154	CcSEcCtD
Sirolimus—Asthenia—Prednisone—rheumatoid arthritis	3.29e-05	0.000154	CcSEcCtD
Sirolimus—Pain—Methotrexate—rheumatoid arthritis	3.28e-05	0.000153	CcSEcCtD
Sirolimus—Pruritus—Prednisone—rheumatoid arthritis	3.25e-05	0.000151	CcSEcCtD
Sirolimus—Feeling abnormal—Methotrexate—rheumatoid arthritis	3.16e-05	0.000147	CcSEcCtD
Sirolimus—Diarrhoea—Prednisone—rheumatoid arthritis	3.14e-05	0.000146	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	3.13e-05	0.000146	CcSEcCtD
Sirolimus—Nausea—Betamethasone—rheumatoid arthritis	3.13e-05	0.000146	CcSEcCtD
Sirolimus—Nausea—Dexamethasone—rheumatoid arthritis	3.13e-05	0.000146	CcSEcCtD
Sirolimus—Dizziness—Prednisone—rheumatoid arthritis	3.03e-05	0.000142	CcSEcCtD
Sirolimus—Abdominal pain—Methotrexate—rheumatoid arthritis	3.03e-05	0.000141	CcSEcCtD
Sirolimus—Body temperature increased—Methotrexate—rheumatoid arthritis	3.03e-05	0.000141	CcSEcCtD
Sirolimus—Vomiting—Prednisone—rheumatoid arthritis	2.92e-05	0.000136	CcSEcCtD
Sirolimus—Rash—Prednisone—rheumatoid arthritis	2.89e-05	0.000135	CcSEcCtD
Sirolimus—Dermatitis—Prednisone—rheumatoid arthritis	2.89e-05	0.000135	CcSEcCtD
Sirolimus—Headache—Prednisone—rheumatoid arthritis	2.87e-05	0.000134	CcSEcCtD
Sirolimus—Hypersensitivity—Methotrexate—rheumatoid arthritis	2.82e-05	0.000132	CcSEcCtD
Sirolimus—Asthenia—Methotrexate—rheumatoid arthritis	2.75e-05	0.000128	CcSEcCtD
Sirolimus—Nausea—Prednisone—rheumatoid arthritis	2.72e-05	0.000127	CcSEcCtD
Sirolimus—Pruritus—Methotrexate—rheumatoid arthritis	2.71e-05	0.000127	CcSEcCtD
Sirolimus—Diarrhoea—Methotrexate—rheumatoid arthritis	2.62e-05	0.000122	CcSEcCtD
Sirolimus—Dizziness—Methotrexate—rheumatoid arthritis	2.54e-05	0.000118	CcSEcCtD
Sirolimus—Vomiting—Methotrexate—rheumatoid arthritis	2.44e-05	0.000114	CcSEcCtD
Sirolimus—Rash—Methotrexate—rheumatoid arthritis	2.42e-05	0.000113	CcSEcCtD
Sirolimus—Dermatitis—Methotrexate—rheumatoid arthritis	2.41e-05	0.000113	CcSEcCtD
Sirolimus—Headache—Methotrexate—rheumatoid arthritis	2.4e-05	0.000112	CcSEcCtD
Sirolimus—Nausea—Methotrexate—rheumatoid arthritis	2.28e-05	0.000106	CcSEcCtD
Sirolimus—MTOR—Signaling Pathways—GZMB—rheumatoid arthritis	1.23e-05	8.86e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MED1—rheumatoid arthritis	1.23e-05	8.86e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TYK2—rheumatoid arthritis	1.23e-05	8.84e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—STAT1—rheumatoid arthritis	1.23e-05	8.84e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.22e-05	8.79e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PTK2—rheumatoid arthritis	1.22e-05	8.78e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—C3—rheumatoid arthritis	1.21e-05	8.71e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL10—rheumatoid arthritis	1.21e-05	8.71e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NOS3—rheumatoid arthritis	1.2e-05	8.68e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	1.2e-05	8.65e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1A—rheumatoid arthritis	1.2e-05	8.63e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL18—rheumatoid arthritis	1.19e-05	8.61e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL3—rheumatoid arthritis	1.19e-05	8.6e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL2—rheumatoid arthritis	1.19e-05	8.6e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD80—rheumatoid arthritis	1.19e-05	8.6e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	1.19e-05	8.58e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD40LG—rheumatoid arthritis	1.19e-05	8.58e-05	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—rheumatoid arthritis	1.19e-05	8.55e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD8A—rheumatoid arthritis	1.18e-05	8.48e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CSF2—rheumatoid arthritis	1.18e-05	8.48e-05	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—IL6—rheumatoid arthritis	1.17e-05	8.45e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TYK2—rheumatoid arthritis	1.17e-05	8.44e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	1.17e-05	8.43e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SAA1—rheumatoid arthritis	1.17e-05	8.42e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ENO1—rheumatoid arthritis	1.16e-05	8.39e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CD4—rheumatoid arthritis	1.16e-05	8.36e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NOS3—rheumatoid arthritis	1.15e-05	8.29e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—AGER—rheumatoid arthritis	1.15e-05	8.27e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.14e-05	8.25e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6ST—rheumatoid arthritis	1.14e-05	8.25e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NCF1—rheumatoid arthritis	1.14e-05	8.24e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ACP5—rheumatoid arthritis	1.14e-05	8.24e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—B3GNT2—rheumatoid arthritis	1.14e-05	8.24e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GC—rheumatoid arthritis	1.14e-05	8.2e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGES—rheumatoid arthritis	1.14e-05	8.2e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS2—rheumatoid arthritis	1.13e-05	8.18e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-B—rheumatoid arthritis	1.13e-05	8.16e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—LEP—rheumatoid arthritis	1.12e-05	8.11e-05	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CD4—rheumatoid arthritis	1.11e-05	8.03e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CD4—rheumatoid arthritis	1.11e-05	8e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6R—rheumatoid arthritis	1.1e-05	7.97e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP3—rheumatoid arthritis	1.1e-05	7.95e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD80—rheumatoid arthritis	1.1e-05	7.94e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—rheumatoid arthritis	1.1e-05	7.94e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—IL6—rheumatoid arthritis	1.1e-05	7.93e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CD28—rheumatoid arthritis	1.1e-05	7.92e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.09e-05	7.85e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ENO1—rheumatoid arthritis	1.07e-05	7.7e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—FN1—rheumatoid arthritis	1.06e-05	7.65e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PTK2—rheumatoid arthritis	1.06e-05	7.65e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL2RA—rheumatoid arthritis	1.06e-05	7.64e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PLB1—rheumatoid arthritis	1.06e-05	7.63e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.06e-05	7.62e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—C3—rheumatoid arthritis	1.05e-05	7.58e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-A—rheumatoid arthritis	1.05e-05	7.56e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.04e-05	7.51e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL5—rheumatoid arthritis	1.04e-05	7.5e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—UBE2D1—rheumatoid arthritis	1.03e-05	7.46e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—BGN—rheumatoid arthritis	1.03e-05	7.42e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CSF2—rheumatoid arthritis	1.02e-05	7.39e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.02e-05	7.38e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6R—rheumatoid arthritis	1.02e-05	7.36e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CXCL8—rheumatoid arthritis	1.02e-05	7.35e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CD80—rheumatoid arthritis	1.02e-05	7.33e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL12—rheumatoid arthritis	1.01e-05	7.32e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.01e-05	7.32e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	1.01e-05	7.27e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TYK2—rheumatoid arthritis	1.01e-05	7.26e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADRBK1—rheumatoid arthritis	1e-05	7.23e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1e-05	7.22e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—rheumatoid arthritis	1e-05	7.21e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—NFKB1—rheumatoid arthritis	9.99e-06	7.2e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CCR5—rheumatoid arthritis	9.93e-06	7.16e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—MAPK8—rheumatoid arthritis	9.82e-06	7.08e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL2—rheumatoid arthritis	9.74e-06	7.02e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—MTHFR—rheumatoid arthritis	9.7e-06	7e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—HLA-A—rheumatoid arthritis	9.67e-06	6.98e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—POMC—rheumatoid arthritis	9.66e-06	6.97e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SPP1—rheumatoid arthritis	9.63e-06	6.95e-05	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—NFKB1—rheumatoid arthritis	9.59e-06	6.92e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TLR4—rheumatoid arthritis	9.58e-06	6.91e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HLA-DRB1—rheumatoid arthritis	9.57e-06	6.91e-05	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—rheumatoid arthritis	9.57e-06	6.9e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALOX5—rheumatoid arthritis	9.46e-06	6.83e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—RASGRP1—rheumatoid arthritis	9.46e-06	6.82e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCL2—rheumatoid arthritis	9.45e-06	6.82e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	9.45e-06	6.82e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SYK—rheumatoid arthritis	9.43e-06	6.8e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6R—rheumatoid arthritis	9.42e-06	6.8e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IFNG—rheumatoid arthritis	9.42e-06	6.8e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCR5—rheumatoid arthritis	9.37e-06	6.76e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—TYK2—rheumatoid arthritis	9.29e-06	6.7e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MED1—rheumatoid arthritis	9.27e-06	6.69e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PRKCQ—rheumatoid arthritis	9.26e-06	6.68e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2RA—rheumatoid arthritis	9.23e-06	6.66e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—rheumatoid arthritis	9.21e-06	6.65e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ICAM1—rheumatoid arthritis	9.19e-06	6.63e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6ST—rheumatoid arthritis	9.19e-06	6.63e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—C3—rheumatoid arthritis	9.15e-06	6.6e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS3—rheumatoid arthritis	9.12e-06	6.58e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NFKB1—rheumatoid arthritis	9.12e-06	6.58e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CD4—rheumatoid arthritis	9.1e-06	6.56e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—STAT1—rheumatoid arthritis	9.09e-06	6.56e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL10—rheumatoid arthritis	8.96e-06	6.47e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MAPK8—rheumatoid arthritis	8.96e-06	6.46e-05	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—rheumatoid arthritis	8.85e-06	6.39e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD80—rheumatoid arthritis	8.84e-06	6.38e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	8.67e-06	6.26e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	8.62e-06	6.22e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ACP5—rheumatoid arthritis	8.62e-06	6.22e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TYK2—rheumatoid arthritis	8.58e-06	6.19e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LEP—rheumatoid arthritis	8.52e-06	6.15e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6ST—rheumatoid arthritis	8.48e-06	6.12e-05	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—rheumatoid arthritis	8.45e-06	6.09e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOS3—rheumatoid arthritis	8.42e-06	6.08e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS2—rheumatoid arthritis	8.42e-06	6.07e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1B—rheumatoid arthritis	8.4e-06	6.06e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—CD4—rheumatoid arthritis	8.4e-06	6.06e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL2—rheumatoid arthritis	8.37e-06	6.04e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CAT—rheumatoid arthritis	8.37e-06	6.04e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—rheumatoid arthritis	8.34e-06	6.02e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—VEGFA—rheumatoid arthritis	8.27e-06	5.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6R—rheumatoid arthritis	8.2e-06	5.91e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP3—rheumatoid arthritis	8.18e-06	5.9e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD80—rheumatoid arthritis	8.17e-06	5.89e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	8.1e-06	5.84e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—FN1—rheumatoid arthritis	8.04e-06	5.8e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6ST—rheumatoid arthritis	8e-06	5.77e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—rheumatoid arthritis	7.95e-06	5.74e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	7.93e-06	5.72e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PTK2—rheumatoid arthritis	7.87e-06	5.68e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—NFKB1—rheumatoid arthritis	7.84e-06	5.65e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—BGN—rheumatoid arthritis	7.76e-06	5.6e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL5—rheumatoid arthritis	7.72e-06	5.57e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	7.72e-06	5.57e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—MAPK8—rheumatoid arthritis	7.71e-06	5.56e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CD80—rheumatoid arthritis	7.7e-06	5.56e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CAT—rheumatoid arthritis	7.68e-06	5.54e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	7.66e-06	5.53e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CSF2—rheumatoid arthritis	7.6e-06	5.48e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—rheumatoid arthritis	7.59e-06	5.48e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6R—rheumatoid arthritis	7.57e-06	5.46e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCL8—rheumatoid arthritis	7.47e-06	5.39e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TYK2—rheumatoid arthritis	7.47e-06	5.39e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—POMC—rheumatoid arthritis	7.32e-06	5.28e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	7.2e-06	5.2e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL2—rheumatoid arthritis	7.16e-06	5.17e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SPP1—rheumatoid arthritis	7.15e-06	5.15e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	7.14e-06	5.15e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL2—rheumatoid arthritis	7.14e-06	5.15e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6R—rheumatoid arthritis	7.14e-06	5.15e-05	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	7.14e-06	5.15e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	7.01e-06	5.05e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GC—rheumatoid arthritis	7.01e-06	5.05e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IFNG—rheumatoid arthritis	6.99e-06	5.04e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—MTHFR—rheumatoid arthritis	6.99e-06	5.04e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCR5—rheumatoid arthritis	6.95e-06	5.01e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TYK2—rheumatoid arthritis	6.89e-06	4.97e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2RA—rheumatoid arthritis	6.85e-06	4.94e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—C3—rheumatoid arthritis	6.79e-06	4.9e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—rheumatoid arthritis	6.77e-06	4.88e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—rheumatoid arthritis	6.76e-06	4.88e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CD4—rheumatoid arthritis	6.75e-06	4.87e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NFKB1—rheumatoid arthritis	6.69e-06	4.82e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MAPK8—rheumatoid arthritis	6.57e-06	4.74e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	6.51e-06	4.7e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TYK2—rheumatoid arthritis	6.5e-06	4.69e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MTHFR—rheumatoid arthritis	6.41e-06	4.63e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—rheumatoid arthritis	6.38e-06	4.61e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LEP—rheumatoid arthritis	6.32e-06	4.56e-05	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—rheumatoid arthritis	6.27e-06	4.52e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TP53—rheumatoid arthritis	6.25e-06	4.51e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—rheumatoid arthritis	6.24e-06	4.5e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—CD4—rheumatoid arthritis	6.23e-06	4.5e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL2—rheumatoid arthritis	6.21e-06	4.48e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—rheumatoid arthritis	6.19e-06	4.46e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—VEGFA—rheumatoid arthritis	6.07e-06	4.38e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—rheumatoid arthritis	6.03e-06	4.35e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—rheumatoid arthritis	5.99e-06	4.32e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—FN1—rheumatoid arthritis	5.96e-06	4.3e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6ST—rheumatoid arthritis	5.94e-06	4.29e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ENO1—rheumatoid arthritis	5.82e-06	4.2e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NFKB1—rheumatoid arthritis	5.82e-06	4.2e-05	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—rheumatoid arthritis	5.72e-06	4.13e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—MAPK8—rheumatoid arthritis	5.72e-06	4.12e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CD80—rheumatoid arthritis	5.72e-06	4.12e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MED1—rheumatoid arthritis	5.71e-06	4.12e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—rheumatoid arthritis	5.66e-06	4.09e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—POMC—rheumatoid arthritis	5.59e-06	4.03e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—rheumatoid arthritis	5.57e-06	4.02e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CAT—rheumatoid arthritis	5.55e-06	4.01e-05	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.44e-06	3.93e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—POMC—rheumatoid arthritis	5.43e-06	3.92e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL2—rheumatoid arthritis	5.41e-06	3.9e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—rheumatoid arthritis	5.32e-06	3.83e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	5.31e-06	3.83e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	5.31e-06	3.83e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6R—rheumatoid arthritis	5.3e-06	3.82e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—POMC—rheumatoid arthritis	5.13e-06	3.7e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—rheumatoid arthritis	5.12e-06	3.7e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ALB—rheumatoid arthritis	5.09e-06	3.67e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NFKB1—rheumatoid arthritis	5.07e-06	3.66e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MAPK8—rheumatoid arthritis	4.98e-06	3.59e-05	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—rheumatoid arthritis	4.92e-06	3.55e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—rheumatoid arthritis	4.87e-06	3.52e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TYK2—rheumatoid arthritis	4.83e-06	3.48e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—BGN—rheumatoid arthritis	4.78e-06	3.45e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—rheumatoid arthritis	4.74e-06	3.42e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ALB—rheumatoid arthritis	4.68e-06	3.37e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	4.63e-06	3.34e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—VEGFA—rheumatoid arthritis	4.6e-06	3.32e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TP53—rheumatoid arthritis	4.59e-06	3.31e-05	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—rheumatoid arthritis	4.54e-06	3.28e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—rheumatoid arthritis	4.47e-06	3.23e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—rheumatoid arthritis	4.47e-06	3.23e-05	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—rheumatoid arthritis	4.46e-06	3.21e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	4.4e-06	3.17e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—rheumatoid arthritis	4.22e-06	3.05e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—rheumatoid arthritis	4.2e-06	3.03e-05	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—rheumatoid arthritis	4.2e-06	3.03e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CAT—rheumatoid arthritis	4.19e-06	3.02e-05	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—rheumatoid arthritis	4.09e-06	2.95e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL2—rheumatoid arthritis	4.02e-06	2.9e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—rheumatoid arthritis	3.8e-06	2.74e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NFKB1—rheumatoid arthritis	3.76e-06	2.71e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—POMC—rheumatoid arthritis	3.71e-06	2.67e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MAPK8—rheumatoid arthritis	3.7e-06	2.67e-05	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—rheumatoid arthritis	3.65e-06	2.63e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	3.59e-06	2.59e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	3.5e-06	2.52e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TP53—rheumatoid arthritis	3.48e-06	2.51e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—VEGFA—rheumatoid arthritis	3.41e-06	2.46e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ALB—rheumatoid arthritis	3.38e-06	2.44e-05	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—rheumatoid arthritis	3.37e-06	2.43e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	3.23e-06	2.33e-05	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—rheumatoid arthritis	3.18e-06	2.29e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—rheumatoid arthritis	3.13e-06	2.26e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	2.96e-06	2.13e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—POMC—rheumatoid arthritis	2.8e-06	2.02e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.58e-06	1.86e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TP53—rheumatoid arthritis	2.58e-06	1.86e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ALB—rheumatoid arthritis	2.55e-06	1.84e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—rheumatoid arthritis	2.44e-06	1.76e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—rheumatoid arthritis	2.36e-06	1.7e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	2.23e-06	1.61e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	2.15e-06	1.55e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.72e-06	1.24e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.57e-06	1.13e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.5e-06	1.08e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.37e-06	9.92e-06	CbGpPWpGaD
